LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,891,000 | +14.8% | 924,831 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $6,004,000 | +1.3% | 863,583 | +19.9% | 0.00% | 0.0% |
| Q3 2016 | $5,926,000 | +5.6% | 720,363 | +4.0% | 0.00% | 0.0% |
| Q2 2016 | $5,611,000 | +64.8% | 692,784 | +3.4% | 0.00% | – |
| Q1 2016 | $3,405,000 | -34.0% | 670,103 | +0.2% | 0.00% | -100.0% |
| Q4 2015 | $5,163,000 | +53.9% | 668,897 | +14.9% | 0.00% | – |
| Q3 2015 | $3,355,000 | -22.4% | 582,225 | +23.5% | 0.00% | – |
| Q2 2015 | $4,326,000 | – | 471,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,229,916 | $26,582,000 | 9.98% |
| FRAZIER MANAGEMENT LLC | 2,087,281 | $17,178,000 | 8.43% |
| Avoro Capital Advisors LLC | 4,257,347 | $35,038,000 | 6.15% |
| Broadfin Capital, LLC | 2,638,259 | $21,713,000 | 1.95% |
| Perceptive Advisors | 3,567,553 | $29,360,000 | 1.90% |
| Opaleye Management Inc. | 280,000 | $2,304,000 | 1.21% |
| Ghost Tree Capital, LLC | 825,000 | $6,790,000 | 1.10% |
| Rhenman & Partners Asset Management AB | 650,000 | $5,349,500,000 | 0.85% |
| QVT Financial LP | 1,751,509 | $14,335,000 | 0.54% |
| Cormorant Asset Management, LP | 505,941 | $4,164,000 | 0.46% |